[ Neoton and thrombolytic therapy of myocardial infarction ] . 
<br>
<br> AIM To <font color="red">evaluate_1</font> neoton <font color="red">therapy_1</font> <font color="red">effects_1</font> in acute myocardial infarction ( MI ) on <font color="red">systolic_3</font> <font color="red">function_3</font> <font color="red">of_3</font> <font color="red">the_3</font> <font color="red">left_3</font> <font color="red">ventricle_3</font> <font color="red">,_3</font> <font color="red">arrhythmia_3</font> <font color="red">and_3</font> <font color="red">clinical_3</font> <font color="red">symptoms_3</font> <font color="red">in_1</font> <font color="red">patients_1</font> <font color="red">on_1</font> <font color="red">thrombolytic_1</font> <font color="red">therapy_1</font> <font color="red">(_1</font> <font color="red">TLT_1</font> <font color="red">)_1</font> <font color="red">._1</font> 
<br> MATERIAL AND METHODS 106 males with Q - MI entered the study . 47 received treatment without TLT and neoton , 30 patients received TLT with streptokinase preparations , 29 patients were given streptokinase preparations and neoton . <font color="red">Left_4</font> <font color="red">ventricular_4</font> <font color="red">systolic_4</font> <font color="red">function_4</font> <font color="red">was_1</font> <font color="red">measured_1</font> <font color="red">by_1</font> <font color="red">echocardiography_1</font> on day 1 , 3 , 7 , 14 , 21 and 28 ; <font color="red">arrhythmia_3</font> <font color="red">was_1</font> <font color="red">analysed_1</font> <font color="red">at_1</font> <font color="red">Holter_1</font> <font color="red">monitoring_1</font> in day 1 and 2 of MI . 
<br> RESULTS TLT failed to arrest <font color="red">progression_1</font> <font color="red">of_1</font> <font color="red">left_2</font> <font color="red">ventricular_2</font> <font color="red">dilation_2</font> by the end of the hospital stay . Patients given neoton in acute period of MI had no increase in the <font color="red">end_3</font> <font color="red">systolic_3</font> <font color="red">and_3</font> <font color="red">diastolic_3</font> <font color="red">volumes_3</font> <font color="red">of_3</font> <font color="red">the_3</font> <font color="red">left_3</font> <font color="red">ventricle_3</font> in the course of the first months after MI onset . <font color="red">Antiarrhythmic_2</font> <font color="red">action_2</font> of neoton manifested on MI day 2 . 
<br> CONCLUSION Neoton given to MI patients receiving TLT prevents <font color="red">progression_2</font> <font color="red">of_2</font> <font color="red">left_2</font> <font color="red">ventricular_2</font> <font color="red">systolic_2</font> <font color="red">dysfunction_2</font> <font color="red">and_1</font> <font color="red">establishment_1</font> <font color="red">of_1</font> <font color="red">predictors_1</font> <font color="red">of_1</font> <font color="red">unfavourable_1</font> <font color="red">outcome_1</font> <font color="red">._1</font>